1. Home
  2. CIGI vs BIO Comparison

CIGI vs BIO Comparison

Compare CIGI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIGI
  • BIO
  • Stock Information
  • Founded
  • CIGI 1972
  • BIO 1952
  • Country
  • CIGI Canada
  • BIO United States
  • Employees
  • CIGI 22940
  • BIO N/A
  • Industry
  • CIGI
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CIGI
  • BIO Industrials
  • Exchange
  • CIGI Nasdaq
  • BIO Nasdaq
  • Market Cap
  • CIGI 7.7B
  • BIO 7.7B
  • IPO Year
  • CIGI N/A
  • BIO N/A
  • Fundamental
  • Price
  • CIGI $151.37
  • BIO $302.54
  • Analyst Decision
  • CIGI Buy
  • BIO Strong Buy
  • Analyst Count
  • CIGI 7
  • BIO 4
  • Target Price
  • CIGI $174.33
  • BIO $333.50
  • AVG Volume (30 Days)
  • CIGI 115.8K
  • BIO 219.1K
  • Earning Date
  • CIGI 11-04-2025
  • BIO 10-29-2025
  • Dividend Yield
  • CIGI 0.20%
  • BIO N/A
  • EPS Growth
  • CIGI N/A
  • BIO N/A
  • EPS
  • CIGI 2.21
  • BIO 11.49
  • Revenue
  • CIGI $5,169,495,000.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • CIGI $16.18
  • BIO $2.12
  • Revenue Next Year
  • CIGI $7.46
  • BIO $2.90
  • P/E Ratio
  • CIGI $68.49
  • BIO $26.34
  • Revenue Growth
  • CIGI 16.63
  • BIO N/A
  • 52 Week Low
  • CIGI $100.86
  • BIO $211.43
  • 52 Week High
  • CIGI $170.65
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • CIGI 30.71
  • BIO 56.19
  • Support Level
  • CIGI $150.86
  • BIO $266.71
  • Resistance Level
  • CIGI $155.96
  • BIO $311.43
  • Average True Range (ATR)
  • CIGI 3.16
  • BIO 8.41
  • MACD
  • CIGI -1.25
  • BIO 2.08
  • Stochastic Oscillator
  • CIGI 2.66
  • BIO 66.08

About CIGI Colliers International Group Inc. Subordinate Voting Shares

Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: